In The News

Dementia now Britain's biggest killer, overtaking heart disease for first time

Westwood One Radio: Alzheimer’s Disease

ProMIS Neurosciences Lead Product Candidate, PMN310, Shows Desired Target Binding Profile in Direct Comparison to Other Amyloid Beta-Directed Antibodies for Alzheimer's Disease

Axovant to pull plug on Alzheimer's drug after key study fails

Possible 'Best-in-Class' Alzheimer's Drug Candidate Offers 'Disruptive' Potential

ProMIS Neurosciences could have a groundbreaking Alzheimer’s treatment, Mackie Research says

Reuters: BRIEF-ProMIS Neurosciences designates PMN330 as 3rd, validated lead product for development in alzheimer’s disease

Life Science Leader: Company to Watch: ProMIS Neurosciences

BRIEF-Promis Neurosciences increases size of private placement to $6 mln

‘Ninja drug’ prevents Alzheimer’s by destroying harmful cells in the brain